Intraductal Healthcare & Breast Endoscopy
Medical researchers have long recognized that 95% of all breast disease originates in the epithelial lining of the mammary duct system. It is well established that in its early stages, most breast disease develops very slowly and remains confined to the mammary ducts for up to 7-10 years. The analysis of individualized ductal systems provides the means to deliver personalized breast health care at the earliest signs of breast cancer risk.
Breast Endoscopy (Mammary ductoscopy) is a fiberoptic technology with the ability to view and collect epithelial cells and other abnormalities in the tiny mammary ducts of the breasts — abnormalities so small they are often missed on mammogram and ultrasound tests.
MammoView - How it Works
MammoView is a fiberoptic technology with the ability to view and collect epithelial cells and other abnormalities in the tiny milk ducts of your breasts — abnormalities so small they are often missed on mammogram and ultrasound tests. MammoView uses a tiny (0.9 mm in diameter) fiberoptic, flexible scope that is inserted into the mammary duct through the nipple and threaded through the labyrinth of mammary ducts deep in the breast. Unlike mammography or other x-ray “pictures,” mammary ductoscopy allows the physician to actually see in “real-time” and in color what is happening inside the mammary ducts.
MammoView is currently available in our Solos Endoscopy line of products. To learn more or purchase please click here
Intraductal Healthcare & Nipple Aspirate Fluid
NAF analysis is an objective assessment of a patient's breast health and can detect early warning signs of ductal cellular changes. Regular assessment and tracking of cellular changes in the milk ducts, where most breast cancer begins, enables clinicians and patients to take control of breast health.
HALO - How it Works
Nipple Aspirate Fluid Collection
The HALO system is a noninvasive device that utilizes proprietary technology to obtain nipple aspirate fluid (''NAF'') samples that can then be used to perform molecular diagnostics and facilitate early identification of breast cancer risk
A Division of CYductDX
Solos Endoscopy, Inc. is a thirty-year-old healthcare technology company whose mission is to market breakthrough technology, medical devices utilized in minimally invasive procedural techniques for the treatment and management of disease and medical conditions. When it comes to endoscopy, Solos’ was a pioneer. Its early work in laparoscopic endoscopy allowed it to become a market leader achieving a significant market share within its early years. Today, Solos focuses on maintaining its core customers with the products and services they have come to expect.